Loading...

Savita Bhakta

Title(s)Assistant Adjunct Professor, Psychiatry
SchoolHealth Sciences
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology. 2019 Aug 24. PMID: 31445502.
      View in: PubMed
    2. Ranganathan M, De Aquino JP, Cortes-Briones JA, Radhakrishnan R, Pittman B, Bhakta S, D'Souza DC. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl). 2019 Jun 11. PMID: 31187152.
      View in: PubMed
    3. Downs N, Alderman T, Bhakta S, Greenwood TA. Implementing a college mental health program - an overview of the first twelve months. J Am Coll Health. 2019 Jan; 67(1):27-31. PMID: 29601286.
      View in: PubMed
    4. Swerdlow NR, Bhakta SG, Light GA. Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. Schizophr Res. 2018 09; 199:285-291. PMID: 29627173.
      View in: PubMed
    5. Bhakta SG, Light GA, Talledo JA, Balvaneda B, Hughes E, Alvarez A, Rana BK, Young JW, Swerdlow NR. Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors. Int J Neuropsychopharmacol. 2017 12 01; 20(12):979-987. PMID: 29020372.
      View in: PubMed
    6. Swerdlow NR, Bhakta SG, Talledo JA, Franz DM, Hughes EL, Rana BK, Light GA. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Neuropsychopharmacology. 2018 03; 43(4):708-717. PMID: 29154367.
      View in: PubMed
    7. Bhakta SG, Young JW. The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species. J Neurosci Methods. 2017 Dec 01; 292:53-60. PMID: 28754432.
      View in: PubMed
    8. Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia. Schizophr Res. 2018 01; 191:87-94. PMID: 28711472.
      View in: PubMed
    9. Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA. Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophr Bull. 2017 07 01; 43(4):872-880. PMID: 27798224.
      View in: PubMed
    10. Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology. 2017 Dec; 42(13):2633-2639. PMID: 28425497.
      View in: PubMed
    11. Swerdlow NR, Bhakta SG, Rana BK, Kei J, Chou HH, Talledo JA. Sensorimotor gating in healthy adults tested over a 15 year period. Biol Psychol. 2017 02; 123:177-186. PMID: 28027936.
      View in: PubMed
    12. Bhakta SG, Chou HH, Rana B, Talledo JA, Balvaneda B, Gaddis L, Light GA, Swerdlow NR. Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. Psychopharmacology (Berl). 2016 06; 233(12):2399-410. PMID: 27076209.
      View in: PubMed
    13. Swerdlow NR, Bhakta S, Chou HH, Talledo JA, Balvaneda B, Light GA. Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology. 2016 Jan; 41(2):419-30. PMID: 26062785.
      View in: PubMed
    14. Mathalon DH, Ahn KH, Perry EB, Cho HS, Roach BJ, Blais RK, Bhakta S, Ranganathan M, Ford JM, D'Souza DC. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. Front Psychiatry. 2014; 5:3. PMID: 24478731.
      View in: PubMed
    15. D'Souza DC, Radhakrishnan R, Perry E, Bhakta S, Singh NM, Yadav R, Abi-Saab D, Pittman B, Chaturvedi SK, Sharma MP, Bell M, Andrade C. Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study. Neuropsychopharmacology. 2013 Feb; 38(3):492-503. PMID: 23093223.
      View in: PubMed
    16. Abbs B, Achalia RM, Adelufosi AO, Aktener AY, Beveridge NJ, Bhakta SG, Blackman RK, Bora E, Byun MS, Cabanis M, Carrion R, Castellani CA, Chow TJ, Dmitrzak-Weglarz M, Gayer-Anderson C, Gomes FV, Haut K, Hori H, Kantrowitz JT, Kishimoto T, Lee FH, Lin A, Palaniyappan L, Quan M, Rubio MD, Ruiz de AzĂșa S, Sahoo S, Strauss GP, Szczepankiewicz A, Thompson AD, Trotta A, Tully LM, Uchida H, Velthorst E, Young JW, O'Shea A, Delisi LE. The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res. 2012 Oct; 141(1):e1-e24. PMID: 22910407.
      View in: PubMed
    17. Bhakta SG, Zhang JP, Malhotra AK. The COMT Met158 allele and violence in schizophrenia: a meta-analysis. Schizophr Res. 2012 Sep; 140(1-3):192-7. PMID: 22784685.
      View in: PubMed
    18. D'Souza DC, Ahn K, Bhakta S, Elander J, Singh N, Nadim H, Jatlow P, Suckow RF, Pittman B, Ranganathan M. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia. Biol Psychiatry. 2012 Nov 01; 72(9):785-94. PMID: 22717030.
      View in: PubMed
    19. Carbuto M, Sewell RA, Williams A, Forselius-Bielen K, Braley G, Elander J, Pittman B, Schnakenberg A, Bhakta S, Perry E, Ranganathan M, D'Souza DC. The safety of studies with intravenous ??-tetrahydrocannabinol in humans, with case histories. Psychopharmacology (Berl). 2012 Feb; 219(3):885-96. PMID: 21845389.
      View in: PubMed
    20. Andrade C, Bhakta SG, Fernandes PP. Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms. Indian J Psychiatry. 2010 Jul; 52(3):260-3. PMID: 21180413.
      View in: PubMed
    21. Shah N, Mahadeshwar S, Bhakta S, Bhirud M, Fernandes P, Andrade C. The safety and efficacy of benzodiazepine-modified treatments as a special form of unmodified ECT. J ECT. 2010 Mar; 26(1):23-9. PMID: 20190597.
      View in: PubMed
    22. Andrade C, Bhakta SG, Singh NM. Systematic enhancement of functioning as a therapeutic technique in conversion disorder. Indian J Psychiatry. 2009 Apr; 51(2):134-6. PMID: 19823633.
      View in: PubMed
    23. Bhakta SG, Andrade C. Melatonin treatment of shoulder-and-neck dyskinesia possibly related to fluoxetine treatment. World J Biol Psychiatry. 2009; 10(4 Pt 3):1047-8. PMID: 19153888.
      View in: PubMed
    24. D'Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl). 2008 Jul; 198(4):587-603. PMID: 18228005.
      View in: PubMed
    25. Andrade C, Bhakta SG, Singh NM. Schizophrenia, osteoporosis, and an examination of the risk of fractures in patients receiving ECT. J ECT. 2007 Dec; 23(4):219-20. PMID: 18090690.
      View in: PubMed
    26. Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb; 68(2):237-41. PMID: 17335321.
      View in: PubMed
    27. Andrade C, Singh NM, Bhakta SG. Simultaneous true seizures and pseudoseizures. J Clin Psychiatry. 2006 Apr; 67(4):673. PMID: 16669735.
      View in: PubMed
    28. Andrade C, Bhakta SG, Singh NM. Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression. World J Biol Psychiatry. 2006; 7(4):251-60. PMID: 17071546.
      View in: PubMed